Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc. USA, has signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks on its MindChain infrastructure. The deals span climate finance, sports media, and insurance, marking a significant expansion of MindWave's blockchain solutions into diverse industries and potentially opening new revenue streams for the parent company.
The agreements include Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform, New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network, and Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under the terms, MindWave will receive contracted fees or equity along with allocations equal to 20% of the applicable credits or tokens, providing opportunities for recurring revenue as the networks become operational. This structure aligns MindWave's success with the growth of each network, creating a scalable income model that could benefit Apimeds shareholders if the platforms gain traction.
The strategic importance of these agreements lies in their cross-industry application. Climate finance is a rapidly growing sector as global efforts to combat climate change intensify, and blockchain-based environmental credit platforms like AQUAEChain could bring much-needed transparency and efficiency to carbon markets. In sports media, FlashChain's digital ticketing and authentication network addresses longstanding issues of fraud and scalping, potentially revolutionizing fan engagement and event access. Meanwhile, AssureChain's focus on insurance and reinsurance leverages blockchain to streamline claims processing and reduce fraud, a sector ripe for disruption.
For Apimeds, these deals represent a diversification beyond its core pharmaceutical business, leveraging MindWave's technology to tap into high-growth markets. However, the company also reiterated that its audited consolidated financial statements for 2025 included an explanatory paragraph from its independent auditor expressing substantial doubt about its ability to continue as a going concern. This disclosure, made pursuant to NYSE American requirements, underscores the financial risks facing the company and does not amend previous filings. Investors should weigh the potential of these blockchain initiatives against the company's going concern warning, as the success of these networks could be critical to improving Apimeds' financial position.
To view the full press release, visit https://ibn.fm/UPsNX. The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS. MissionIR, a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, and enhanced press release enhancement. For more information, please visit MissionIR.
